These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3536793)

  • 21. [Cancer blood-borne metastasis and platelets].
    Tanaka K; Fukumoto S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2453-9. PubMed ID: 6391385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of human pancreatic cancer cell proteinases: role of cell membrane metalloproteinases in collagenolysis and cytolysis.
    Zucker S; Lysik RM; Wieman J; Wilkie DP; Lane B
    Cancer Res; 1985 Dec; 45(12 Pt 1):6168-78. PubMed ID: 2998595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin.
    Honn KV; Cavanaugh P; Evens C; Taylor JD; Sloane BF
    Science; 1982 Aug; 217(4559):540-2. PubMed ID: 7046053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma].
    Imashuku S; Esumi N; Todo S; Nakajima F
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):775-80. PubMed ID: 6585182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of phosphodiesterase inhibitors on platelet aggregation and tumor metastasis.
    Ambrus JL; Ambrus CM; Gastpar H
    Ric Clin Lab; 1981; 11 Suppl 1():197-207. PubMed ID: 6324323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line.
    Esumi N; Todo S; Imashuku S
    Cancer Res; 1987 Apr; 47(8):2129-35. PubMed ID: 3829002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
    Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
    Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles.
    Cavanaugh PG; Sloane BF; Bajkowski AS; Gasic GJ; Gasic TB; Honn KV
    Clin Exp Metastasis; 1983; 1(4):297-307. PubMed ID: 6400436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG; Onoda JM; Taylor JD; Honn KV
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-aggregating activities of metastasizing tumor cells. II. Variety of the aggregation mechanisms.
    Tohgo A; Tanaka N; Ashida S; Ogawa H
    Invasion Metastasis; 1984; 4(3):134-45. PubMed ID: 6480287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is epinephrine-induced platelet aggregation autoregulated by its metabolic degradation products in vivo?
    Evangelou AM; Malamas MP; Vezyraki P; Karkabounas SC
    In Vivo; 1998; 12(3):321-5. PubMed ID: 9706478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteinases and proteinase inhibition by cytotoxic and antimetastatic drugs in transplantable solid metastasizing tumors in mice.
    Giraldi T; Sava G; Perissin L; Zorzet S
    Anticancer Res; 1985; 5(4):355-9. PubMed ID: 3898994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the platelet-aggregating activity of cancer cells with different metastatic potential.
    Grignani G; Pacchiarini L; Almasio P; Pagliarino M; Gamba G; Rizzo SC; Ascari E
    Int J Cancer; 1986 Aug; 38(2):237-44. PubMed ID: 3733262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of blood platelets and prostaglandins in blood-borne metastases].
    Tanaka K; Fukumoto S
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1944-7. PubMed ID: 6614932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor cells induce platelet aggregation and intraplatelet calcium ion movements.
    Pacchiarini L; Zucchella M; Eynard AR; Grignani G
    Platelets; 1993; 4(5):275-9. PubMed ID: 21043751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell surface sialylation of two human tumor cell lines and its correlation with their platelet-activating activity.
    Bastida E; Almirall L; Jamieson GA; Ordinas A
    Cancer Res; 1987 Apr; 47(7):1767-70. PubMed ID: 2880661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26.
    Toyoshima M; Nakajima M; Yamori T; Tsuruo T
    Cancer Res; 1995 Feb; 55(4):767-73. PubMed ID: 7850787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis.
    Amirkhosravi A; Amaya M; Siddiqui F; Biggerstaff JP; Meyer TV; Francis JL
    Platelets; 1999; 10(5):285-92. PubMed ID: 16801104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanidinophenyl derivatives of pyrazole: synthesis and inhibitory effect on serine proteinases, blood coagulation and platelet aggregation.
    Ferroni R; Menegatti E; Scalia S; Orlandini P; Guarneri M; Taddeo U
    Farmaco Sci; 1986 Oct; 41(10):747-57. PubMed ID: 3539635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.